| abstract |
Novel peptide mimetic compounds are provided which have useful activity as inhibitors of platelet aggregation. These compounds have the chemical structuren wherein nx = 6 to 10, ny = 0 to 4, nZ = H, COOH, CONHâ‚‚ or Cl-6 alkyl, nAr = phenyl, biphenyl or napthyl, each substituted with 1 to 3 methoxy groups, or an unsubstituted phenyl, biphenyl, napthyl, pyridyl or thienyl group, and nAsp = aspartic acid residue. |